(Total Views: 378)
Posted On: 10/18/2019 12:22:12 PM
Post# of 145247
![Avatar](https://investorshangout.com/images/ProfileImages/167738657_59587_mando klein.jpg)
Re: the lawman #9688
But lowering triglycerides isn't the only MOA of VASCEPA (EVAPORATE resukts in November will likely show plaque reduction and reduction of inflammation) and further to get a CVD label Matinas would need to do a 5-year outcomes study which they can't afford and will consume significant funds.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)